News Results
There are 370,829 News Results
Jun 14, 2017
SHANGHAI, June 15, 2017 /PRNewswire/ -- ReneSola Ltd ("ReneSola" or the "Company") ( www.renesola.com ) (NYSE: SOL), a leading fully-integrated solar project developer and provider of energy efficient technology products,...
Jun 14, 2017
ATLANTA, June 15, 2017 /PRNewswire/ -- Jack Cooper Enterprises, Inc. ("JCEI") and Jack Cooper Holdings Corp. ("JCHC" and, together with JCEI, the "Company") announced today the Company has signed a...
Jun 20, 2017
SLOUGH, UK and RICHMOND, Va., June 21, 2017 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the presentation of results from its pivotal Phase 3 clinical trial (RB-US-13-0001) evaluating the...
Jun 21, 2017
EAST HANOVER, N.J., June 22, 2017 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) approval of Tafinlar(®) (dabrafenib) in combination with Mekinist(®) (trametinib) to treat patients...
Jun 27, 2017
TORRANCE, Calif., June 28, 2017 /PRNewswire/ -- The 2018 model year brings significant updates to the third generation of the versatile 5-door subcompact Honda Fit including fresh sportier styling, a...
Jul 18, 2017
NEW YORK, July 19, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Mobile Social Networking in terms of Number of Users. The report provides separatecomprehensive analytics for the...
Jul 19, 2017
WALLDORF, Germany, July 20, 2017 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced its financial results for the second quarter 2017 ended June 30, 2017. "This strong quarter is the...
Jul 19, 2017
BEIJING, July 20, 2017 /PRNewswire/ -- Zhaopin Limited (NYSE: ZPIN) ("Zhaopin" or the "Company"), a leading career platform([1]) in China focused on connecting users with relevant job opportunities throughout their...
Jul 12, 2017
HORSHAM, Pa., July 13, 2017 /PRNewswire/ -- Janssen Biotech, Inc.(Janssen) announced today that the U.S. Food and Drug Administration (FDA) has approved TREMFYA(TM) (guselkumab) for the treatment of adults living...
Jul 17, 2017
SAN FRANCISCO, July 18, 2017 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced positive topline results from an oral Human Abuse Potential (HAP) study of NKTR-181, a first-in-class opioid analgesic. NKTR-181...